QI
MYGN icon

QS Investors’s Myriad Genetics MYGN Stock Holding History

QS Investors’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4,600
Closed -$126K – 1681
2019
Q4 		$126K Hold
4,600
– – ﹤0.01% 1321
2019
Q3 		$132K Sell
4,600
-26
-0.6% -$758 ﹤0.01% 1307
2019
Q2 		$129K Hold
4,626
– – ﹤0.01% 1330
2019
Q1 		$154K Hold
4,626
– – ﹤0.01% 1293
2018
Q4 		$135K Buy
4,626
+4,600
+17,692% +$165K ﹤0.01% 1247
2018
Q3 		$1K Hold
26
– – ﹤0.01% 1795
2018
Q2 		$1K Hold
26
– – ﹤0.01% 1818
2018
Q1 		$1K Buy
+26
New +$880 ﹤0.01% 1836
2017
Q4 		– Sell
-4,283
Closed -$155K – 2001
2017
Q3 		$155K Sell
4,283
-1,867
-30% -$53.3K ﹤0.01% 1320
2017
Q2 		$159K Hold
6,150
– – ﹤0.01% 1297
2017
Q1 		$118K Hold
6,150
– – ﹤0.01% 1367
2016
Q4 		$103K Hold
6,150
– – ﹤0.01% 1274
2016
Q3 		$127K Hold
6,150
– – ﹤0.01% 1209
2016
Q2 		$188K Sell
6,150
-15
-0.2% -$521 ﹤0.01% 1107
2016
Q1 		$231K Buy
6,165
+8
+0.1% +$301 ﹤0.01% 1054
2015
Q4 		$266K Buy
6,157
+7
+0.1% +$296 ﹤0.01% 1037
2015
Q3 		$231K Sell
6,150
-7,000
-53% -$248K ﹤0.01% 1041
2015
Q2 		$447K Hold
13,150
– – 0.01% 896
2015
Q1 		$466K Sell
13,150
-4,926
-27% -$176K 0.01% 890
2014
Q4 		$616K Buy
+18,076
New +$641K 0.01% 823
2014
Q3 		– Sell
-25,200
Closed -$981K – 777
2014
Q2 		$981K Buy
+25,200
New +$938K 0.03% 386
2013
Q4 		– Sell
-317,700
Closed -$7.47M – 609
2013
Q3 		$7.47M Buy
317,700
+255,700
+412% +$7.26M 0.32% 92
2013
Q2 		$1.67M Buy
+62,000
New +$1.8M 0.06% 308

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

QS Investors's MYGN Position: Q1 2020 in Review

QS Investors sold out of Myriad Genetics (MYGN) in Q1 2020, closing a stake of 4,600 shares — an estimated $126K sold.

QS Investors first reported a position in MYGN in Q2 2013 and held it in 23 quarters. The position peaked at $7.47M in Q3 2013. 190 funds tracked by Wall St. Rank hold MYGN as of Q1 2020.

  • QS Investors reported no remaining Myriad Genetics position as of Q1 2020 after selling out during the quarter.
  • QS Investors sold 4,600 Myriad Genetics shares in Q1 2020, an estimated $126K.
  • QS Investors first reported a position in Myriad Genetics in Q2 2013 and held it in 23 quarters.
  • QS Investors's Myriad Genetics position peaked at $7.47M in Q3 2013.
  • 190 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2020.

Based on QS Investors's 13F filing for Q1 2020, filed 15 May 2020.